Results 121 to 130 of about 45,004 (157)

The lights went out.

, 2012
Cavelaars, Chen, Cholesterol Treatment Trialists' Ctt Collaboration, Kromhout, Kunitz, Leon, S. Ebrahim, Uusitalo   +7 more
core   +1 more source

The New Era of Pneumococcal Vaccination in Adults: What Is Next? [PDF]

Vaccines (Basel)
Ozisik L.
europepmc   +1 more source

Pneumococcal Vaccine Uptake in Adults Before and After Hospitalization for Pneumococcal Infections in Hong Kong, 2015 to 2024. [PDF]

Vaccines (Basel)
Chan KF, Ma TF, Ho JC, Hung IF, Ip MS, Ho PL.   +5 more
europepmc   +1 more source

Coverage disparities and delayed immunization: Assessing 12-month vaccination completion in Canadian children using data from a digital immunization platform. [PDF]

Hum Vaccin Immunother
Serhan M, Nilormi A, Ntacyabukura B, Atkinson K, Ducharme R, Hawken S, Ramsay T, Ang J, Wilson K.   +8 more
europepmc   +1 more source

Correction to: The Complex Landscape of Updated Pneumococcal Conjugate Vaccines. [PDF]

Open Forum Infect Dis
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pneumococcal vaccination

Current Opinion in Infectious Diseases, 2016
Pneumococcal diseases (invasive diseases, pneumonia, otitis media, and sinusitis) are among the most frequent preventable infectious diseases carrying a very high morbidity and case fatality rate worldwide. Pneumococcal vaccination is a key element to reduce the global burden of the disease in children and adult population.
Catia, Cillóniz, Rosanel, Amaro, Antoni, Torres   +2 more
openaire   +2 more sources

Pneumococcal vaccines

Drugs of Today, 1999
Despite advances in our knowledge of the pathogenesis and host immune response and efforts at prevention and treatment, S. pneumoniae continues to cause considerable disease and mortality. The currently available polysaccharide vaccines confer moderate protection in most adults and older children, but they are underutilized.
J D, Campbell, M B, Rennels
openaire   +2 more sources